Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
PF-06425090 by Pfizer for Clostridioides difficile Infections (Clostridium difficile Associated Disease): Likelihood of Approval
PF-06425090 is under clinical development by Pfizer and currently in Phase III for Clostridioides difficile Infections (Clostridium difficile Associated Disease)....
Data Insights
REC-163964 by Recursion Pharmaceuticals for Clostridioides difficile Infections (Clostridium difficile Associated Disease): Likelihood of Approval
REC-163964 is under clinical development by Recursion Pharmaceuticals and currently in Phase I for Clostridioides difficile Infections (Clostridium difficile Associated...